Pralsetinib - Mashandisirwo, Chipimo, Migumisiro Yemushonga uye Zvimwe

Pralsetinib mushonga wekurapa wakanangana unoshandiswa zvakanyanya mukurapa mamwe marudzi ekenza, kunyanya kenza yemapapu isiri diki (NSCLC) ine genetic mutations chaiyo. Inorongwa semushonga unodzivirira RET (yakagadziriswazve panguva ye transfection) kinase, iyo inoita basa rakakosha mumigwagwa yekutumira zviratidzo zvemasero inokurudzira kukura kwemasero ekenza. Nekudzivisa kinase iyi, Pralsetinib inobatsira kunonoka kana kumisa kukura kwemasero ekenza, zvichiita kuti ive sarudzo yakakosha kune varwere vane RET fusion positive tumors.

Mashandisirwo ePralsetinib

Pralsetinib inotenderwa kurapa varwere vakuru vane kenza yemapapu isiri diki (NSCLC) iyo ine RET gene fusions. Inoratidzwawo kune varwere vane kenza yethyroid yeRET-mutant medullary (MTC) yepamusoro kana yakapararira. Zviratidzo izvi zvinoratidza basa rePralsetinib mukutarisa shanduko dzemajini mumabundu, zvichibvumira nzira yakasarudzika yekurapa kenza.

Pralsetinib Inoshanda Sei?

Pralsetinib inoshanda nekutarisa nekudzivisa mashandiro eRET kinase, iyo inobatanidzwa munzira dzekutumira zviratidzo dzinosimudzira kupatsanurwa kwemasero uye kurarama. Mukenza dzine RET fusions, iyi kinase inowanzo shanda zvakanyanya, zvichikonzera kukura kusingadzoreki kwemasero ekenza. Nekuvharira RET, Pralsetinib inokanganisa zviratidzo izvi, zvichideredza kana kumisa kuwanda kwemasero ekenza. Iyi nzira inobvumira kurwisa kwakanyanya pamasero ekenza uku ichichengetedza masero akajairwa, izvo zvinogona kukonzera migumisiro mishoma kana tichienzanisa nechemotherapy yechinyakare.

Chipimo chemushonga uye Administration

Chipimo chePralsetinib kuvanhu vakuru chinowanzo torwa nemuromo 400 mg kamwe chete pazuva. Zvakakosha kutora mushonga panguva imwe chete zuva rega rega kuti muviri urambe uine huwandu hwakafanana. Pralsetinib inogona kutorwa nechikafu kana pasina chikafu, asi zvinokurudzirwa kuti usatore mushonga uyu nekudya kwakawanda mafuta, sezvo izvi zvingakanganisa kunwa kwemushonga. Kune varwere vevana, chiyero chacho chinogona kusiyana zvichienderana nehuremu uye chinofanira kusarudzwa nemupi wehutano. Pralsetinib inofanira kutorwa mudumbu risina chinhu - chikafu chisina chinhu kwemaawa maviri usati watora mushonga uye awa imwe chete mushure mekutora mushonga - kuitira kuti muviri unyatso nwa zvakanaka.

Migumisiro yePralsetinib

Kufanana nemishonga yese, Pralsetinib inogona kukonzera migumisiro yakaipa. Migumisiro yakaipa inosanganisira:

• Kuneta
• Nausea
• Diarrhea
• Constipation
• Kuwedzera kwechiropa enzymes
• Hypertension (yakakwira ropa)

Serious side effects inogona kusanganisira:

• Chirwere chemapapu chemukati memapapu (kuzvimba kwemapapu)
• Zvinetso zvechiropa
• Yakanyanya sema maitiro
• Mwoyo rhythm inoshanduka

Varwere vanofanira kuudza chiremba wavo zviratidzo zvisingawanzoitika nekukurumidza.

Kubatana Kwemishonga

Pralsetinib inogona kushanda pamwe chete nemishonga yakasiyana-siyana, izvo zvinogona kukanganisa mashandiro ayo kana kuwedzera njodzi yemigumisiro yakaipa. Kushanda pamwe chete nemishonga iyi kunosanganisira:

• Yakasimba CYP3A4 inhibitors (semuenzaniso, ketoconazole, ritonavir)
• Mishonga yakasimba yeCYP3A4 (semuenzaniso, rifampin, St. John's Wort)
• Mimwe mishonga inokanganisa ma enzymes echiropa

Nekuti Pralsetinib inogadziriswa ne enzyme yechiropa inonzi CYP3A4, kungwarira kunodiwa ne CYP3A4 inhibitors yakasimba (yakadai se ketoconazole, ritonavir) uye inducers (yakadai se rifampin, St. John's Wort). Izvi zvingada kugadziriswa kwemushonga kana kudzivirira kushandiswa panguva imwe chete. Zvakakosha kuti varwere vazivise mupi wehutano hwavo nezvemishonga yese, mishonga yekuwedzera, uye mishonga yemiti yavari kutora kuti vadzivise kusangana kwemishonga iyi.

Mabhenefiti ePralsetinib

Chinhu chikuru chinobatsira chePralsetinib ndechekuti inorwisa maronda ane RET-positive, izvo zvinogona kutungamira mukuvandudzwa kwekurapwa kwevarwere vane majini chaiwo. Zvidzidzo zvekiriniki, kusanganisira bvunzo yeARROW, zvakaratidza kuti Pralsetinib inotungamira mukuderera kwegomarara uye inobatsira kuchengetedza chirwere ichi kwenguva yakareba muvarwere vane RET fusion-positive non-small cell lung cancer (NSCLC) uye RET-mutant medullary thyroid cancer (MTC). Pamusoro pezvo, kupiwa kwayo nemuromo kunoita kuti zvive nyore kana tichienzanisa nekurapwa netsinga, zvichiwedzera kutevedzera zvinodiwa nemurwere.

Zvimwe zvinopesana nePralsetinib

Pralsetinib haibvumidzwe mumishonga yekurapa mune mamwe marudzi emishonga, kusanganisira:

• Varwere vane hypersensitivity kuPralsetinib kana chimwe chezvikamu zvayo.
• Vakadzi vane pamuviri kana kuti vanoyamwisa, sezvo zvingakuvadza mwana ari mudumbu kana mucheche.
• Varwere vane chirwere chechiropa chakakomba vanogona kuwedzera njodzi yemigumisiro yakaipa.

Kushandisa nzira dzekudzivirira pamuviri dzinoshanda kunodiwa panguva yekurapwa nePralsetinib uye kwemavhiki maviri mushure memushonga wekupedzisira, sezvo Pralsetinib inogona kukuvadza mwana asati aberekwa. Zvakakosha kuti varwere vakurukure nhoroondo yavo yehutano nevanopa rubatsiro rwehutano vasati vatanga kurapwa.

Chenjedzo uye Nyevero

Vasati vatanga kushandisa Pralsetinib, varwere vanofanira kuongororwa zvakadzama kusanganisira kuongororwa kwebasa rechiropa, kuongororwa kwehutano hwemapapu, uye kuyerwa kweropa, sezvo mushonga uyu uchigona kukonzera chepfu muchiropa, kuzvimba kwemapapu, uye BP. Panguva yekurapwa, kuongororwa kweropa nguva dzose, ma enzymes echiropa (ALT neAST), uye zviratidzo zvemapapu zvakakosha kuti zvionekwe migumisiro yacho nekukurumidza uye kuti igadziriswe zvinobudirira.

Varwere vanofanira kurayirwa kuti vakurumidze kutaura chero zviratidzo zvitsva kana kuti zviri kuramba zvichiwedzera kuipa, kunyanya matambudziko ekufema akadai sekukosora kana kufema zvishoma, zviratidzo zvekushaya simba kwechiropa zvakaita sejaundice kana kuneta kusingawanzoitiki, kana kuwedzera kweBP. Kuonekwa nekukurumidza kunobvumira vanachiremba kugadzirisa kurapwa sezvinodiwa kuti vave nechokwadi chekuti vakachengeteka.

FAQs

1. Chii chinoshandiswa nePralsetinib?

Pralsetinib inoshandiswa kurapa kenza yemapapu isiri diki (NSCLC) inopararira uye kenza yemudumbu (MTC) inorapa RET gene fusions.

2. Ndinofanira kutora sei Pralsetinib?

Tora Pralsetinib 400 mg nemuromo kamwe chete pazuva, panguva imwe chete zuva rega rega, uine kana usina chikafu.

3. Ndezvipi zvinowanzoitika?

Migumisiro inowanzo sanganisira kuneta, kuda kurutsa, manyoka, uye kuwedzera kwema enzymes echiropa.

4. Ndingatora Pralsetinib pamwe chete nemimwe mishonga here?

Udza chiremba wako nezvemishonga yese yauri kutora, sezvo Pralsetinib inogona kukanganisa mimwe mishonga.

5. Ko Pralsetinib yakachengeteka here panguva yekuzvitakura?

Kwete, Pralsetinib haibvumidzwe kunwa kuvakadzi vane pamuviri nekuda kwekukuvadza mwana ari mudumbu.

6. Ndingaitei kana ndikarasikirwa nedosi?

Kana ukarasikirwa nedosi, tora pakarepo paunoyeuka. Kana yave pedyo nedosi rinotevera, svetuka dosi rakapotsa uye enderera nehurongwa hwako hwenguva dzose.

7. Pralsetinib inoshanda sei?

Pralsetinib inodzivisa RET kinase, ichikanganisa zviratidzo zvinokurudzira kukura kwemasero ekenza.

8. Pane mimwe migumisiro yakaipa here?

Ehe, migumisiro yakaipa inogona kusanganisira kuzvimba kwemapapu nematambudziko echiropa. Taura chero zviratidzo zvisingawanzoitika kuna chiremba wako.

9. Ndinganwa doro here ndichitora Pralsetinib?

Zvakanaka kubvunza chiremba wako nezvekushandisa doro paunenge uchinwa Pralsetinib, sezvo zvingakanganisa mashandiro echiropa.

10. Ndichatora Pralsetinib kwenguva yakareba sei?

Nguva yekurapwa inosiyana zvichienderana nemhinduro yemunhu uye migumisiro yekurapwa. Chiremba wako ndiye achasarudza chirongwa chakakunakira.

Mazita eBrand

Pralsetinib inotengeswa pasi pezita rekuti Gavreto. Zvakakosha kuti ubvunze chiremba wako kana murapi wemishonga kuti uwane mushonga uyu here uye kuti ungaushandisa sei.

mhedziso

Pralsetinib inomiririra kufambira mberi kukuru mukurapa kenza yeRET fusion positive, kunyanya kenza yemapapu isiri diki uye kenza yemedullary thyroid. Maitiro ayo ekuita anopa sarudzo inovimbisa kune varwere vane majini akasiyana, zvichitungamira kumhedzisiro iri nani uye hupenyu hwakanaka. Sezvimwe nemishonga chero ipi zvayo, zvakakosha kuti varwere vashande pamwe chete nevanovapa hutano kuti vave nechokwadi chekurapa kwakachengeteka uye kunobudirira.